With the rise of AI, have you ever wondered how life sciences startups should approach AI compliance in their day-to-day operations and product offerings? Click through to discover the key insights and actionable steps you can take to navigate AI regulations with confidence!
Southeast Asia’s cities are booming but so are its environmental challenges.
From gene-edited rice to oil-eating microbes, biotechnology is emerging as a quiet but powerful ally in tackling waste, pollution, and food security.
Our latest article explores how environmental biotech can turn these challenges into engines of resilience and growth for the region.
The Geneo x BCS: Biotech Writing Challenge was held in 2025 where participants wrote perspective articles on the evolving biotech and medtech landscape in Singapore and Asia. Our 1st prize winner— Ng Qin Xiang, shares an insightful perspective on how glocalization should be the guiding principle for medtech in the 21st century.
The Geneo x BCS: Biotech Writing Challenge was held in 2025 where participants wrote perspective articles on the evolving biotech and medtech landscape in Singapore and Asia. Our 2nd prize winner— Toh Qin Kane, shares an informative piece on the potential of liquid biopsies to transform the biotech landscape in Asia.
The Geneo x BCS: Biotech Writing Challenge was held in 2025 where participants wrote perspective articles on the evolving biotech and medtech landscape in Singapore and Asia. Our 3rd prize winner— Tay Jian Hua, provides a comprehensive analysis of how Singapore is fast becoming Asia’s hub for longevity innovation.
On 14 March 2024, the U.S. Food and Drug Administration (FDA) approved the first treatment for noncirrhotic non-alcoholic steatohepatitis (NASH) with moderate to advanced liver scarring, to be used along with diet and exercise [1]. NASH is the more serious stage of non-alcoholic fatty liver disease (NAFLD), a silent killer affecting up to 40% of the population in Singapore [2].
The 1st BCS Biotech Writing Competition was held in 2023 where applicants submitted their entries on current biotechnology trends and opinions in Asia. In the wake of the COVID-19 pandemic and the perpetual outbreaks of Influenza, most of us see microbes as dangerous organisms. Our 3rd prize winner, Vanessa Lunardi, writes an informative piece that proves otherwise – maybe microbes can be used to benefit humankind after all.
The 1st BCS Biotech Writing Competition was held in 2023 where applicants submitted their entries on current biotechnology trends and opinions in Asia. Our 1st runner up, Yap Wee Swan, provides a comprehensive, yet personal, perspective of cellular agriculture in Southeast Asia.
The 1st BCS Biotech Writing Competition was held in 2023 where applicants submitted their entries on current biotechnology trends and opinions in Asia. The winning entry by Jingmei Li, PhD shares about precision health screening through personal anecdotes, and its potential applications in early detection of diseases.
Senescence and aging are two terms that many are not familiar with, and they come with their fair share of associated maladies. But with the recent discovery of senolytics, is it possible to halt aging in its tracks? In this joint collaboration with A*STAR, we discuss the current progress and potential of senolytics.